Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Debra S. Echt, Philip R. Liebson, L. Brent Mitchell et al. · New England Journal of Medicine · 1991 · 3.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Philip A. Poole‐Wilson, Karl Swedberg, John G.F. Cleland et al. · The Lancet · 2003 · 1.9K citations · Full text

Medicine, Cardiology, Pharmacology +13

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction

Albert L. Waldo, A. John Camm, Hans deRuyter et al. · The Lancet · 1996 · 1.4K citations

Medicine, Cardiology, Internal Medicine +13

Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

Silvia G. Priori, Carlo Napolitano, Mirella Memmi et al. · Circulation · 2002 · 1.2K citations

Medicine, Cardiology, Genetics +13

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

Hiroshi Watanabe, Nagesh Chopra, Derek R. Laver et al. · Nature Medicine · 2009 · 600 citations · Full text

Medicine, Cardiology, Pharmacology +12